Steven Cohen’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$151K Buy
+78,671
New +$222K ﹤0.01% 3572
2026
Q2
– Sell
-246,615
Closed -$663K – 4048
2026
Q1
$663K Buy
246,615
+189,967
+335% +$527K ﹤0.01% 2997
2025
Q4
$124K Buy
+56,648
New +$140K ﹤0.01% 3713
2025
Q1
– Sell
-1,265,882
Closed -$2.87M – 2077
2024
Q4
$2.87M Buy
1,265,882
+598,607
+90% +$2.1M 0.01% 1125
2024
Q3
$3.15M Buy
+667,275
New +$3.86M 0.01% 1023
2024
Q2
– Sell
-282,651
Closed -$4.82M – 1896
2024
Q1
$4.82M Sell
282,651
-2,015
-0.7% -$43.2K 0.01% 976
2023
Q4
$6.46M Buy
+284,666
New +$4.79M 0.02% 828
2023
Q2
– Sell
-5,243
Closed -$43.4K – 2211
2023
Q1
$43.4K Buy
+5,243
New +$49.1K ﹤0.01% 1811
2022
Q2
– Sell
-725,000
Closed -$1.47M – 1418
2022
Q1
$1.47M Sell
725,000
-225,000
-24% -$588K 0.01% 915
2021
Q4
$3.6M Buy
950,000
+50,000
+6% +$534K 0.01% 738
2021
Q3
$10.9M Buy
+900,000
New +$8.3M 0.05% 463

Other funds holding CABA

Steven Cohen's CABA Position: Q3 2026 in Review

Steven Cohen opened a new position in Cabaletta Bio (CABA) in Q3 2026: 78,671 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #3572 among its holdings. This is a return to the name: Steven Cohen previously reported a position in CABA as recently as Q1 2026.

Steven Cohen first reported a position in CABA in Q3 2021 and has held it in 11 quarters since. The position peaked at $10.9M in Q3 2021. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Steven Cohen held 78,671 shares of Cabaletta Bio worth $151K as of Q3 2026.
  • Cabaletta Bio was a new Steven Cohen position in Q3 2026.
  • Cabaletta Bio made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3572 holding.
  • Steven Cohen first reported a position in Cabaletta Bio in Q3 2021 and has held it in 11 quarters since.
  • Steven Cohen's Cabaletta Bio position peaked at $10.9M in Q3 2021.
  • 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.